Who owns SAB BIOTHERAPEUTICS INC?
- Ticker: SABSW
- CUSIP Number: 78397t111
Tip: Access positions for across all investors
Analyze quarterly positions in Sab Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sab Biotherapeutics stock
Who bought or sold SAB BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| LMR Partners | 540k | $14k | 100% | Mar 2026 |
|
| Morgan Stanley | 146k | $3.7k | 0% | Mar 2026 |
|
| Clear Street Group | 79k | $2.1k | 100% | Mar 2026 |
|
| Millennium Management | 63k | $1.6k | 0% | Mar 2026 |
|
| Gts Securities | 41k | $1.0k | 100% | Dec 2025 |
|
| UBS Group | 4.2k | $105.068600 | -32% | Mar 2026 |
|
| Wolverine Asset Management | 1.8k | $47.086000 | 0% | Mar 2026 |
|
Who sold out of Sab Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2025 | 26k | $749.607000 |